FR2440556A1 - Methode et reactif immunologiques et fixation specifique heterogene combinee - Google Patents

Methode et reactif immunologiques et fixation specifique heterogene combinee

Info

Publication number
FR2440556A1
FR2440556A1 FR7926911A FR7926911A FR2440556A1 FR 2440556 A1 FR2440556 A1 FR 2440556A1 FR 7926911 A FR7926911 A FR 7926911A FR 7926911 A FR7926911 A FR 7926911A FR 2440556 A1 FR2440556 A1 FR 2440556A1
Authority
FR
France
Prior art keywords
reagent
different
marker
simultaneous determination
immunological method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7926911A
Other languages
English (en)
Other versions
FR2440556B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ames Yissum Ltd
Original Assignee
Ames Yissum Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ames Yissum Ltd filed Critical Ames Yissum Ltd
Publication of FR2440556A1 publication Critical patent/FR2440556A1/fr
Application granted granted Critical
Publication of FR2440556B1 publication Critical patent/FR2440556B1/fr
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/819Multifunctional antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'INVENTION A TRAIT AU DOMAINE DE L'ANALYSE MEDICALE. ELLE CONCERNE UNE METHODE ET UN SYSTEME D'ANALYSE PAR FIXATION SPECIFIQUE HETEROGENE POUR LA DETERMINATION SIMULTANEE DE CHACUN DE PLUSIEURS LIGANDS DIFFERENTS DANS UN SEUL ET MEME ECHANTILLON LIQUIDE A ANALYSER. L'EPREUVE PEUT SUIVRE TOUTE TECHNIQUE CLASSIQUE DE TYPE HETEROGENE, C'EST-A-DIRE QU'ELLE PEUT COMPORTER LA SEPARATION ENTRE UNE FORME LIEE ET UNE FORME LIBRE DU REACTIF MARQUE. L'EPREUVE COMBINEE EST CONDUITE EN UTILISANT DES AGENTS EN PHASE SOLIDE DE FIXATION POUR LES LIGANDS RESPECTIFS A DETERMINER QUI SONT DIFFERENTIELLEMENT SEPARABLES LES UNS DES AUTRES, EN PERMETTANT AINSI D'UTILISER UN MARQUEUR UNIQUE PLUTOT QU'UN MARQUEUR DIFFERENT POUR CHAQUE LIGAND A DETERMINER. L'INVENTION S'APPLIQUE PARTICULIEREMENT A LA DETERMINATION SIMULTANEE DE DIFFERENTS ANTICORPS, NOTAMMENT DES ANTICORPS RELATIFS A DIFFERENTS ANTIGENES VIRAUX, DANS UN SEUL ET MEME ECHANTILLON DE SERUM.
FR7926911A 1978-10-30 1979-10-30 Methode et reactif immunologiques et fixation specifique heterogene combinee Granted FR2440556A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL55816A IL55816A (en) 1978-10-30 1978-10-30 Method for simultaneous immunoassay of several different antibodies and a kit therefor

Publications (2)

Publication Number Publication Date
FR2440556A1 true FR2440556A1 (fr) 1980-05-30
FR2440556B1 FR2440556B1 (fr) 1983-09-02

Family

ID=11050628

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7926911A Granted FR2440556A1 (fr) 1978-10-30 1979-10-30 Methode et reactif immunologiques et fixation specifique heterogene combinee

Country Status (11)

Country Link
US (1) US4315907A (fr)
JP (1) JPS5585252A (fr)
AU (1) AU519877B2 (fr)
CA (1) CA1128856A (fr)
DE (1) DE2943648C2 (fr)
FR (1) FR2440556A1 (fr)
GB (1) GB2034466B (fr)
IL (1) IL55816A (fr)
IT (1) IT7950687A0 (fr)
NL (1) NL7907939A (fr)
SE (1) SE7908936L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531223A1 (fr) * 1982-07-31 1984-02-03 Mochida Pharm Co Ltd Procede et reactif de dosage immunologique

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1148859A (fr) * 1979-06-14 1983-06-28 Lacy R. Overby Technique pour le depistage simultane de deux virus de l'hepatite dans un milieu solide
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4446231A (en) * 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
GB2059421A (en) * 1979-10-03 1981-04-23 Self C H Assay method and reagents therefor
AU6295180A (en) * 1979-10-26 1981-04-30 Dynasciences Corp. Competitve binding assay for haptens + antigens
US4849338A (en) * 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4540659A (en) * 1981-04-17 1985-09-10 Syva Company Simultaneous calibration heterogeneous immunoassay
US4533629A (en) * 1981-04-17 1985-08-06 Syva Company Simultaneous calibration heterogeneous immunoassay
US4843000A (en) * 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US5156953A (en) * 1979-12-26 1992-10-20 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
JPH0235944B2 (ja) * 1980-06-20 1990-08-14 Unilever Nv Tokuitekiketsugokenteiojitsushisuruhohooyobigaihohoojitsushisurutamenoshikenkitsuto
EP0146654A3 (fr) * 1980-06-20 1986-08-20 Unilever Plc Procédé et dispositif pour la réalisation d'essais à liaison spécifique
JPS5712363A (en) * 1980-06-24 1982-01-22 Daiichi Rajio Isotope Kenkyusho:Kk Immunoassay for various simultaneous measurement
JPS5745454A (en) * 1980-09-02 1982-03-15 Fuji Photo Film Co Ltd Immunochemical measuring method for various minor components
DE3266735D1 (en) * 1981-02-18 1985-11-14 Eisai Co Ltd An enzyme immuno-assay for simultaneously measuring a plurality of samples and test vessel for carrying out this method
DE3274017D1 (en) * 1981-03-07 1986-12-04 Colin Henry Self Assay and use
IE54109B1 (en) * 1982-02-10 1989-06-21 Boots Celltech Diagnostics Assay
JPS5924256A (ja) * 1982-07-31 1984-02-07 Mochida Pharmaceut Co Ltd 免疫学的測定方法及び試薬
JPS5940166A (ja) * 1982-08-30 1984-03-05 Mochida Pharmaceut Co Ltd 免疫学的測定方法及び試薬
US5599720A (en) * 1982-08-27 1997-02-04 Multilyte Limited Measurement of analyte concentration
DE3322373C2 (de) * 1983-05-19 1986-12-04 Ioannis Dr. 3000 Hannover Tripatzis Testmittel und Verfahren zum Nachweis von Antigenen und/oder Antikörpern
JPS6089755A (ja) * 1983-07-01 1985-05-20 フイリツプ・ジヨン・ベア−ド 診断用試薬及びその製造法並びにそれを用いる診断法
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US4654325A (en) * 1984-05-24 1987-03-31 Selenke William M Medicament for reducing nephrotoxicity caused by positively charged agents such as aminoglycosides and methods of use thereof
US4745075A (en) * 1984-09-06 1988-05-17 Burroughs Wellcome Co. Diagnostic test methods
JPS6181782A (ja) * 1984-09-28 1986-04-25 Teijin Ltd 抗ウイルス・ヒト抗体を産生するマウス−ヒトハイブリド−マ及びその製造法並びにその使用方法
US4808518A (en) * 1985-02-11 1989-02-28 University Of Tennessee Research Corporation Recovery of cytomegalovirus antigen and use thereof in an assay
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4950590A (en) * 1986-01-13 1990-08-21 Board Of Governors Of Wayne State University Method and kit for assay for measurement of serum thymosin alpha1
US4829010A (en) * 1987-03-13 1989-05-09 Tanox Biosystems, Inc. Immunoassay device enclosing matrixes of antibody spots for cell determinations
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
EP0386074A1 (fr) * 1987-11-13 1990-09-12 Armin Dr. Gilak Procede immunologique de fractionnement et de detection pour dosages multiples
US5079172A (en) * 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
CA2008100A1 (fr) * 1989-01-20 1990-07-20 Hubert Bayer Methode de dosage de substances detectables par des methodes immunologique
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
EP0473065A3 (en) * 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
FR2667943B1 (fr) * 1990-10-11 1994-05-13 Jacques Toledano Dispositif et procede pour la determination qualitative et quantitative rapide d'un ligand dans un fluide.
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
WO1993025910A1 (fr) * 1992-06-05 1993-12-23 Pharmacia Biosensor Ab Dosage de plusieurs analytes a l'aide de ligands co-immobilises
JP2611676B2 (ja) * 1994-11-02 1997-05-21 スズキ株式会社 自動車のフレーム
EP0789779A2 (fr) * 1994-11-04 1997-08-20 Idexx Laboratories, Inc. Milieu pour detecter des microbes cibles dans un echantillon
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US20100062461A1 (en) * 2006-07-11 2010-03-11 Leap Biosciences Corporation Multiplex detection of cell surface receptors or immobilized antigens
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2014164594A1 (fr) 2013-03-11 2014-10-09 Meso Scale Technologies, Llc. Procédés améliorés pour conduire des dosages multiplexés

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928553A (en) * 1972-03-23 1975-12-23 Univ New York Radioimmunoassay method for triiodothyronine and thyroxine
FI54842C (fi) * 1977-01-14 1979-03-12 Suovaniemi Finnpipette Formstycke i anordningar foer immunitetsbestaemningar och enzymreaktioner
US4207307A (en) * 1977-01-21 1980-06-10 Research Corporation Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites
DE2803154C2 (de) * 1977-01-27 1986-07-24 Becton, Dickinson and Co., Paramus, N.J. Gleichzeitige Radiountersuchung von Folat und Vitamin B 12
US4135884A (en) * 1977-08-29 1979-01-23 Shen James T Gamma stick
FI56750C (fi) * 1978-02-27 1980-03-10 Reijo Vihko Rekationskaerl foer engaongsbruk vid immunologiskt bestaemning

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531223A1 (fr) * 1982-07-31 1984-02-03 Mochida Pharm Co Ltd Procede et reactif de dosage immunologique

Also Published As

Publication number Publication date
AU5218679A (en) 1980-05-08
IT7950687A0 (it) 1979-10-29
DE2943648A1 (de) 1980-05-14
US4315907A (en) 1982-02-16
CA1128856A (fr) 1982-08-03
SE7908936L (sv) 1980-05-01
JPS5585252A (en) 1980-06-27
IL55816A (en) 1982-04-30
AU519877B2 (en) 1981-12-24
GB2034466B (en) 1983-03-23
FR2440556B1 (fr) 1983-09-02
GB2034466A (en) 1980-06-04
DE2943648C2 (de) 1982-10-21
NL7907939A (nl) 1980-05-02
IL55816A0 (en) 1978-12-17

Similar Documents

Publication Publication Date Title
FR2440556A1 (fr) Methode et reactif immunologiques et fixation specifique heterogene combinee
Büscher et al. Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients
NO931747D0 (no) Fremgangsmaate ved undersoekelse av glycerte blodproteiner,samt anordning for utfoerelse av fremgangsmaaten
FR2447966A1 (fr) Conjugues analogue de ligand-inhibiteur enzymatique irreversible et procedes pour la determination des ligands les utilisant
FR2449895A1 (fr) Determination d'iso-enzymes de creatine kinase au moyen de complexes anticorps-isoenzyme immobilises
Adam et al. Cerebrospinal fluid
KR960029789A (ko) 생체내 물질의 면역학적 분석용 키트 및 면역학적 분석 방법
CA2393127A1 (fr) Epreuve diagnostique de l'accident vasculaire cerebral
FR2425074A1 (fr) Reactif et methode de detection de l'hepatite b
FR2408142A1 (fr) Procede de determination immunochimique utilisant des reactifs marques
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
WO1998005965A1 (fr) Methode d'identification de cellules eucaryotes par fixation desdites cellules sur un support et support pour mettre en oeuvre ladite methode
Siadak et al. Identification of Ly-5 and T200 antigens on identical cell surface proteins.
FR2392386A1 (fr) Procede pour determiner la presence d'antigenes, d'anticorps et de complexes antigene-anticorps dans les liquides
US20020151089A1 (en) Separating components of biological samples
Adewuyi et al. Racial difference between white and black Zimbabweans in the haemolytic activity of A, B, O antibodies
US4681842A (en) Process and reagent for the differentiated determination of isoenzymes of alkaline phosphatase
JP2001503863A (ja) タンパク質の抽出方法
JPH05295000A (ja) 共有結合的交雑種抗体、その調製法およびこれを使用する均質的免疫検定法
NO986218L (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
Bojar et al. Oestrogen-binding components in human renal cell carcinoma
DE60025022D1 (de) Nachweis von hla-g
Secchi et al. Laboratory results of some biological measures in workers exposed to lead
FR2402209A1 (fr) Produit pour l'analyse qualitative ou quantitative de substances dans les liquides aqueux
US3730684A (en) Thyroxine determination method employing the competitive protein binding technique

Legal Events

Date Code Title Description
ST Notification of lapse